Gyeonggi-do, South Korea

Su Yeon Jung

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The Asan Foundation. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Su Yeon Jung. Retrieved from https://idiyas.com/inventor/su-yeon-jung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Su Yeon Jung

Introduction

Su Yeon Jung is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant strides in the field of pharmaceuticals, particularly in the development of protein kinase inhibitors. Her work is crucial for advancing treatments for various diseases.

Latest Patents

Su Yeon Jung holds 1 patent for her invention titled "Protein kinase inhibitor containing pyrrolopyridazine derivative." This invention relates to a pyrrolopyridazine derivative represented by a specific formula, or a pharmaceutically acceptable salt thereof. The compound is designed to inhibit the activity of protein kinase(s), making it valuable for preventing or treating related diseases.

Career Highlights

Su Yeon Jung is associated with the Asan Foundation, where she contributes her expertise in pharmaceutical research and development. Her innovative approach has positioned her as a key figure in her field.

Collaborations

She collaborates with notable colleagues, including Tae Gon Baik and Won-Hyuk Jung, enhancing the impact of her research through teamwork and shared knowledge.

Conclusion

Su Yeon Jung's contributions to the field of pharmaceuticals through her innovative inventions highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…